LATEST NEWS

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug

P&T December 2019
Table of Contents

Features

Strict policies are needed to protect patients.

New treatmetnt has rapid onset of action.

Identifying the best evidence for DOAC use in certain populations.

Case Report
A Case Report of Thrombocytosis in a Patient Receiving Ciprofloxacin and Ceftriaxone

Case report points to risk of ciprofloxacin–ceftriaxone combination.

Perspective

Men might have benefited from getting a more complete ED story.

Editorial

A good bye from Pharmacy and Therapeutics.

Departments

Prescription Washington

Congress divided on drug pricing legislation.

Istradefylline (Nourianz) as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease experiencing “off” episodes.

Industry announcements